EXACT Sciences Company Insiders

EXAS Stock  USD 56.03  1.14  2.08%   
Slightly above 89 percent of EXACT Sciences' insiders are activelly selling. The analysis of the overall insider sentiment regarding EXACT Sciences suggests that a very large number of insiders are panicking. EXACT Sciences employs about 6.5 K people. The company is managed by 18 executives with a total tenure of roughly 34 years, averaging almost 1.0 years of service per executive, having 361.11 employees per reported executive.
Kevin Conroy  Chairman
Chairman of The Board, CEO and Pres

EXACT Sciences' Insider Buying Vs Selling

11

 
Selling
 
Buying

Latest Trades

2024-11-13Kevin T ConroyAcquired 19500 @ 51.35View
2024-10-08Brian BaranickDisposed 929 @ 70View
2024-09-18Brian BaranickDisposed 929 @ 70View
2024-05-10Josh GottheimerDisposed @ 53.51
2024-05-01Kevin T ConroyDisposed 1155 @ 60.15View
2024-04-01Sarah CondellaDisposed 2000 @ 70View
2024-03-28Sarah CondellaDisposed 2000 @ 70View
2024-03-01Sarah CondellaDisposed 1724 @ 59.32View
2024-02-27Kevin T ConroyDisposed 6263 @ 56.89View
Monitoring EXACT Sciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.

Acquired vs Disposed

Filed vs Not Filed

Insider sentiment refers to the collective sentiment or feeling of EXACT Sciences' insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of EXACT Sciences. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe EXACT Sciences' stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

EXACT Sciences' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with EXACT Sciences' future performance. Based on our forecasts, it is anticipated that EXACT will maintain a workforce of slightly above 6500 employees by March 2025.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

EXACT Sciences' latest congressional trading

Congressional trading in companies like EXACT Sciences, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in EXACT Sciences by those in governmental positions are based on the same information available to the general public.
2020-11-20Representative Jim HagedornAcquired Under $15KVerify

EXACT Sciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.0216) % which means that it has lost $0.0216 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0676) %, meaning that it created substantial loss on money invested by shareholders. EXACT Sciences' management efficiency ratios could be used to measure how well EXACT Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.09 in 2025. Return On Capital Employed is likely to drop to -0.03 in 2025. At this time, EXACT Sciences' Intangibles To Total Assets are comparatively stable compared to the past year. Debt To Assets is likely to gain to 0.37 in 2025, whereas Fixed Asset Turnover is likely to drop 1.58 in 2025.
Common Stock Shares Outstanding is likely to gain to about 217.5 M in 2025, despite the fact that Net Loss is likely to grow to (533.1 M).

EXACT Sciences Workforce Comparison

EXACT Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 247,904. EXACT Sciences holds roughly 6,500 in number of employees claiming about 2.62% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03.

EXACT Sciences Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXACT Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXACT Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, EXACT Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
1.0
1
1
 19,500 
 929.00 
2024-09-01
1.0
3
3
 45,514 
 5,016 
2024-06-01
2.0
22
11
 59,964 
 56,381 
2024-03-01
0.6377
44
69
 583,817 
 313,953 
2023-12-01
1.0
4
4
 33,266 
 42,511 
2023-09-01
0.1429
1
7
 2,712 
 44,463 
2023-06-01
1.5556
14
9
 40,537 
 22,116 
2023-03-01
0.6441
38
59
 336,022 
 230,824 
2022-12-01
0.4
2
5
 35,006 
 54,739 
2022-09-01
0.6
3
5
 7,648 
 21,416 
2022-06-01
6.0
12
2
 49,838 
 4,086 
2022-03-01
0.7708
37
48
 824,997 
 525,864 
2021-06-01
1.3571
19
14
 50,084 
 91,883 
2021-03-01
0.527
39
74
 391,101 
 606,663 
2020-12-01
0.1111
4
36
 1,680 
 253,418 
2020-09-01
0.75
24
32
 122,662 
 275,138 
2020-06-01
2.5
5
2
 97,183 
 36,948 
2020-03-01
0.875
21
24
 422,834 
 220,575 
2019-12-01
0.2857
6
21
 24,401 
 212,887 
2019-09-01
0.7083
17
24
 101,455 
 127,720 
2019-06-01
0.4545
5
11
 51,272 
 161,500 
2019-03-01
0.6154
32
52
 1,489,381 
 1,430,421 
2018-12-01
0.1765
3
17
 171,936 
 524,631 
2018-09-01
1.1
11
10
 55,508 
 46,990 
2018-06-01
1.0
7
7
 92,597 
 32,989 
2018-03-01
0.6324
43
68
 1,065,416 
 1,229,411 
2017-12-01
0.3043
7
23
 564,265 
 1,271,391 
2017-09-01
2.0
34
17
 1,197,844 
 297,503 
2017-06-01
1.6667
5
3
 16,608 
 19,936 
2017-03-01
0.5484
17
31
 213,013 
 302,185 
2016-12-01
0.5294
9
17
 1,588,124 
 3,126,439 
2016-09-01
1.6667
15
9
 239,000 
 128,433 
2016-06-01
1.1429
8
7
 501,361 
 537,502 
2016-03-01
0.9697
32
33
 1,654,146 
 635,121 
2015-12-01
1.2
6
5
 165,839 
 164,598 
2015-09-01
1.5
12
8
 168,454 
 124,084 
2015-06-01
0.6667
2
3
 2,177 
 10,640 
2015-03-01
1.0556
19
18
 527,333 
 123,650 
2014-12-01
0.5641
22
39
 807,811 
 2,082,477 
2014-09-01
1.5714
11
7
 169,109 
 107,291 
2014-06-01
2.3333
7
3
 148,464 
 133,766 
2014-03-01
1.2
12
10
 475,825 
 61,359 
2013-12-01
1.2222
11
9
 215,459 
 124,699 
2013-09-01
3.2
16
5
 380,448 
 69,873 
2013-06-01
4.0
4
1
 23,378 
 3,577 
2013-03-01
4.5
9
2
 429,950 
 55,695 
2012-12-01
1.0
9
9
 84,987 
 113,607 
2012-09-01
13.0
13
1
 64,308 
 4,608 
2012-06-01
1.0
2
2
 5,223 
 5,356 
2012-03-01
1.3333
4
3
 397,500 
 5,310 
2011-12-01
0.875
7
8
 304,401 
 106,092 
2011-09-01
3.8
19
5
 183,923 
 30,038 
2011-03-01
1.0
1
1
 300,000 
 0.00 
2010-09-01
7.0
21
3
 252,866 
 10,167 
2010-03-01
1.4
7
5
 51,461 
 17,155 
2009-09-01
9.0
9
1
 646,373 
 0.00 
2009-03-01
0.2
3
15
 1,374,999 
 895,000 
2008-12-01
1.0
1
1
 130,000 
 0.00 
2005-03-01
3.0
3
1
 155,000 
 20,000 
2004-12-01
6.0
6
1
 280,000 
 20,000 

EXACT Sciences Notable Stakeholders

An EXACT Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EXACT Sciences often face trade-offs trying to please all of them. EXACT Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EXACT Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kevin ConroyChairman of The Board, CEO and PresProfile
Kevin JDChairman CEOProfile
Scott CowardSr. VP and General CounselProfile
Graham LidgardChief Science Officer and Sr. VPProfile
James HerriottGeneral VPProfile
Jeffrey CFAChief OfficerProfile
Ana HookerChief OfficerProfile
Aaron BloomerExecutive FinanceProfile
Vic ParkerHead SalesProfile
Sarah CondellaExecutive ResourcesProfile
Sri KalluriChief OfficerProfile
Tim CaprezChief VPProfile
Brian BaranickExecutive OncologyProfile
Nassar NizamiChief OfficerProfile
Everett CunninghamChief OfficerProfile
Jake MBAExecutive ScreeningProfile
Jorge GarcesChief OfficerProfile
Megan JonesAssociate RelationsProfile

About EXACT Sciences Management Performance

The success or failure of an entity such as EXACT Sciences often depends on how effective the management is. EXACT Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of EXACT management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the EXACT management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.08)(0.09)
Return On Capital Employed(0.03)(0.03)
Return On Assets(0.03)(0.03)
Return On Equity(0.06)(0.06)
Please note, the imprecision that can be found in EXACT Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EXACT Sciences. Check EXACT Sciences' Beneish M Score to see the likelihood of EXACT Sciences' management manipulating its earnings.

EXACT Sciences Workforce Analysis

Traditionally, organizations such as EXACT Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EXACT Sciences within its industry.

EXACT Sciences Manpower Efficiency

Return on EXACT Sciences Manpower

Revenue Per Employee384.6K
Revenue Per Executive138.9M
Net Loss Per Employee31.4K
Net Loss Per Executive11.3M
Working Capital Per Employee104.6K
Working Capital Per Executive37.8M

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.